Abstract
BackgroundFor ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) patients, tumor necrosis factor (TNF) inhibitors are recommended when disease activity persists despite non-steroidal anti-inflammatory drugs.ObjectivesTo evaluate the efficacy and safety...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
